SPH-7050

N/A

Report date: 2025/11/03 16:01:30
NME

Base Information

Drug NameSPH-7050
Drug Alias NameSPH7050SPH-7050I039I-039
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanC-like protein 2 agonists
TargetsLanC-like protein 2
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Pharmaceuticals Holding Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Pharmaceuticals Holding Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A